SCHEMBL1905072

SCHEMBL1905072

Nc1ccc(CNC(=O)[C@H](Cc2ccc(F)c(F)c2)NC(=O)C(O)Cc2ccc(F)cc2)cn1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 3/20 0.46
KLKB1 P03952 2/20 0.42
PDPK1 O15530 2/20 0.41
PSMB1 P20618 1/20 0.41
PSMB5 P28074 1/20 0.41
PSMB2 P49721 1/20 0.41
FURIN P09958 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MASP2 O00187 2/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HDAC1 Q13547 1/20 0.36
MME P08473 1/20 0.36
ACE P12821 1/20 0.36
CPA1 P15085 1/20 0.36
ACE2 Q9BYF1 1/20 0.36
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1903988 1.00 NAMPT (0.46) NAMPTKLKB1PDPK1PSMB1PSMB5
Trifluoroacetic Acid SCHEMBL1906072 0.95 NAMPT (0.42) NAMPTKLKB1PDPK1PSMB1PSMB5
SCHEMBL1901814 0.93 KLKB1 (0.49) NAMPTKLKB1PDPK1PSMB1PSMB5
SCHEMBL1901351 0.93 KLKB1 (0.42) NAMPTKLKB1PDPK1PSMB1PSMB5
SCHEMBL1901348 0.93 KLKB1 (0.42) NAMPTKLKB1PDPK1PSMB1PSMB5
SCHEMBL1901817 0.93 KLKB1 (0.49) NAMPTKLKB1PDPK1PSMB1PSMB5
SCHEMBL1903701 0.91 PDPK1 (0.48) NAMPTKLKB1PDPK1PSMB1PSMB5
SCHEMBL1903704 0.91 PDPK1 (0.48) NAMPTKLKB1PDPK1PSMB1PSMB5
SCHEMBL1906121 0.90 KLKB1 (0.43) NAMPTKLKB1PDPK1PSMB1PSMB5
SCHEMBL1904483 0.90 NAMPT (0.45) NAMPTKLKB1FURINALDH1A1MASP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011051671-A1 AMINOPYRIDINE DERIVATIVES AS KALLIKREIN INHIBITORS VANTIA LIMITED (GB) 2011-05-05 WO disclosed